Development and validation of the VISAGE AmpliSeq basic tool to predict appearance and ancestry from DNA.
AmpliSeq
Appearance and bio-geographical ancestry prediction
Forensic DNA phenotyping
MPS Ion S5
SNP multiplex
Journal
Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
13
02
2020
revised:
28
05
2020
accepted:
08
06
2020
pubmed:
4
7
2020
medline:
13
7
2021
entrez:
4
7
2020
Statut:
ppublish
Résumé
Forensic DNA phenotyping is gaining interest as the number of applications increases within the forensic genetics community. The possibility of providing investigative leads in addition to conventional DNA profiling for human identification provides new insights into otherwise "cold" police investigations. The ability of reporting on the bio-geographical ancestry (BGA), appearance characteristics and age based on DNA obtained from a crime scene sample of an unknown donor makes the exploration of such markers and the development of new methods meaningful for criminal investigations. The VISible Attributes through GEnomics (VISAGE) Consortium aims to disseminate and broaden the use of predictive markers and develop fully optimized and validated prototypes for forensic casework implementation. Here, the first VISAGE appearance and ancestry tool development, performance and validation is reported. A total of 153 SNPs (96.84 % assay conversion rate) were successfully incorporated into a single multiplex reaction using the AmpliSeq™ design pipeline, and applied for massively parallel sequencing with the Ion S5 platform. A collaborative effort involving six VISAGE laboratory partners was devised to perform all validation tests. An extensive validation plan was carefully organized to explore the assay's overall performance with optimum and low-input samples, as well as with challenging and casework mock samples. In addition, forensic validation studies such as concordance and mixture tests recurring to the Coriell sample set with known genotypes were performed. Finally, inhibitor tolerance and specificity were also evaluated. Results showed a robust, highly sensitive assay with good overall concordance between laboratories.
Identifiants
pubmed: 32619960
pii: S1872-4973(20)30109-5
doi: 10.1016/j.fsigen.2020.102336
pii:
doi:
Substances chimiques
Genetic Markers
0
DNA
9007-49-2
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
102336Subventions
Organisme : NHGRI NIH HHS
ID : UM1 HG008901
Pays : United States
Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.